Avastin risk to fetus

Avastin.Possible risk for the fetus is an addendum to the main Avastin consent form. Use it for women of child-bearing age. This consent form was revised on 11/5/15.

The main Avastin consent form is at www.omic.com/Avastin/.

Avastin

There are two Avastin consent forms

• Use the Avastin form for all adult patients receiving Avastin. This form was revised on 3/13/20.
• Ask women of child-bearing age to sign Avastin.Possible risk for the fetus about the possible risk to the fetus. This form was revised on 11/5/15.

Review our risk management recommendations on the use of anti-VEGF drugs in adults.

Anti-VEGF drugs for adults addresses on- and off-label use, preventing endophthalmitis, informed consent issues, and documentation. It incorporates key guidelines on intravitreal injection published by a panel of experts. It also addresses the FDA warning about Avastin in more detail.

Conduct a time out before each intravitreal injection.

OMIC has received reports of “wrong” events associated with intravitreal injections. These include wrong patient, wrong eye, wrong condition, wrong drug, and wrong dose.

To ensure that the correct drug and dose are injected into the correct eye every time, the ophthalmologist needs to lead a time out.  Time out before intravitreal injections provides the opportunity to confirm that the patient, medical record, and ophthalmologist are in agreement.

Fall Prevention

In an issue of the Ophthalmic Risk Management Digest devoted to falls, we examined the circumstances surrounding the falls, determined factors that increased their likelihood, and offered suggestions on ways to identify and assist those most at risk. Fall Prevention  summarizes the risk management recommendations. Please see that issue of the Digest for additional case studies, an analysis of the difference between professional liability and premises liability claims related to falls, and information on money paid to settle these claims: http://www.omic.com/2015-v25-n2/.

OMIC Digest Archives 2015

	OMIC Digest: Vol. 25 | No. 4 | 2015 Feature: Young ophthalmologists on trial Eye on OMIC: New regulatory and cyber liability (e-MD®) benefits Policy Issues: MPL insurance for young ophthalmologists Closed Claim Study: Second cataract surgery proceeds when CRVO goes undetected Risk Management Hotline: What may I safely delegate? < click to view or download
	OMIC Digest: Vol. 25 | No. 3 | 2015 Feature: Giant cell arteritis claims are costly and difficult to defend Eye on OMIC: Rate decrease and policyholder dividend approved for 2016 Policy Issues: National Practitioner Data Bank reporting Closed Claim Study: Poor communication between providers delays GCA diagnosis Risk Management Hotline: Clear communication is key to timely diagnosis and treatment < click to view or download
	OMIC Digest: Vol. 25 | No. 2 | 2015 Feature: When patients fall, are doctors to blame? Eye on OMIC: Insurance for tangential perils of medical practice Policy Issues: Liability and coverage for patient falls Closed Claim Study: Hip fracture in 90-year-old female patient following fall in exam room Risk Management Hotline: Help patients reduce their risk of falling in your office or ASC < click to view or download
	OMIC Digest: Vol. 25 | No. 1 | 2015 Feature: Call early, call often: Benefits of proactive incident reporting Eye on OMIC: Regulatory and cyber liability (e-MD®) resources Policy Issues: Additional benefits under OMIC’s policy Closed Claim Study: Monovision misunderstanding leads to health department complaint Risk Management Hotline: When is a physician-patient relationship established? < click to view or download

2015 V25 N2

http://www.omic.com/wp-content/uploads/2015/06/Digest-V25-N2-20151.pdf